PIM1 and acute myeloid leukemia: Since SEL24-B489 inhibits FLT3 mutants and simultaneously blocks activity of PIM kinases (the key downstream effectors of FLT3 signaling), we hypothesized that these properties should lead to broader toxicity of the compound against AML cells in comparison to selective PIM or FLT3 inhibitors.